VIVIMEDLAB.NSVIVIMEDLAB.NSNSE

Revenue (LTM)

$1.2B

-22.0% YoY

Net Income (LTM)

$-320M

+29.7% YoY

Free Cash Flow

$-86M

Revenue CAGR (5Y)

-35.8%

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	8,615	2,373↓72.5%	1,871↓21.2%	1,491↓20.3%	1,163↓22.0%
Gross Profit	5,069	838↓83.5%	-929↓210.8%	706↑176.0%	78↓89.0%
Operating Income	-69	-251↓265.9%	-1,218↓385.8%	-148↑87.8%	-333↓124.6%
Net Income	-778	-677↑13.0%	-3,285↓385.6%	-454↑86.2%	-320↑29.7%
EBITDA	336	-68↓120.2%	-1,859↓2637.9%	-247↑86.7%	-87↑64.8%
EPS Diluted	-9.38	-8.16↑13.0%	-39.62↓385.5%	-5.48↑86.2%	-3.85↑29.7%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	64	72↑11.7%	38↓47.6%	16↓56.8%	7↓56.5%
Total Current Assets	5,287	5,073↓4.1%	3,323↓34.5%	3,426↑3.1%	3,276↓4.4%
Total Assets	12,893	12,660↓1.8%	9,883↓21.9%	9,509↓3.8%	9,208↓3.2%
Total Current Liabilities	3,414	3,738↑9.5%	4,243↑13.5%	4,103↓3.3%	4,082↓0.5%
Total Liabilities	8,578	9,017↑5.1%	9,489↑5.2%	9,564↑0.8%	9,560↓0.0%
Total Equity	4,316	3,643↓15.6%	394↓89.2%	-55↓113.9%	-352↓544.0%
Total Debt	2,527	2,783↑10.2%	3,810↑36.9%	3,788↓0.6%	3,763↓0.6%
Net Debt	2,462	2,711↑10.1%	3,773↑39.1%	3,772↓0.0%	3,756↓0.4%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	5,673	-6,585↓216.1%	138↑102.1%	-240↓273.7%	-41↑82.9%
Capital Expenditure	0	-164	-50↑69.7%	-20↑59.0%	-45↓122.2%
Free Cash Flow	5,673	-6,749↓219.0%	304↑104.5%	-260↓185.8%	-86↑66.9%
Stock-Based Comp	0	0	0	0	0
Net Change in Cash	-441	931↑311.4%	-34↓103.7%	-17↑49.3%	-13↑24.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance